Stjepan Uldrijan

1.5k total citations
34 papers, 1.2k citations indexed

About

Stjepan Uldrijan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Stjepan Uldrijan has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Stjepan Uldrijan's work include Cancer-related Molecular Pathways (13 papers), Ubiquitin and proteasome pathways (9 papers) and Epigenetics and DNA Methylation (4 papers). Stjepan Uldrijan is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Ubiquitin and proteasome pathways (9 papers) and Epigenetics and DNA Methylation (4 papers). Stjepan Uldrijan collaborates with scholars based in Czechia, United Kingdom and Germany. Stjepan Uldrijan's co-authors include Vladimı́r Kryštof, Karen H. Vousden, Willem‐Jan Pannekoek, Kai Schuh, Ludwig Neyses, Iva Slaninová, Eva Táborská, Bořivoj Vojtěšek, Zbyněk Zdráhal and Stepan Gambaryan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Stjepan Uldrijan

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stjepan Uldrijan Czechia 18 897 372 163 144 83 34 1.2k
Larissa Kotelevets France 20 966 1.1× 317 0.9× 198 1.2× 211 1.5× 103 1.2× 29 1.5k
Katrina Diener United States 13 1.3k 1.5× 237 0.6× 231 1.4× 199 1.4× 203 2.4× 18 1.7k
Joseph Lee United States 17 1.7k 1.9× 305 0.8× 144 0.9× 143 1.0× 75 0.9× 31 1.9k
Lea Guo United States 16 1.1k 1.2× 198 0.5× 119 0.7× 289 2.0× 85 1.0× 21 1.4k
Rasmus Ree Norway 10 1.0k 1.1× 567 1.5× 139 0.9× 78 0.5× 74 0.9× 14 1.3k
Troy Ketela Canada 20 1.2k 1.3× 228 0.6× 154 0.9× 214 1.5× 101 1.2× 41 1.4k
Clive Mason United Kingdom 13 1.6k 1.7× 336 0.9× 118 0.7× 307 2.1× 116 1.4× 21 1.9k
Sally A. Prigent United Kingdom 16 775 0.9× 483 1.3× 114 0.7× 188 1.3× 95 1.1× 23 1.3k
Lluís López-Barcons United States 16 742 0.8× 305 0.8× 186 1.1× 103 0.7× 136 1.6× 44 1.3k
Dwight M. Morrow United States 14 950 1.1× 213 0.6× 142 0.9× 180 1.3× 191 2.3× 33 1.3k

Countries citing papers authored by Stjepan Uldrijan

Since Specialization
Citations

This map shows the geographic impact of Stjepan Uldrijan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stjepan Uldrijan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stjepan Uldrijan more than expected).

Fields of papers citing papers by Stjepan Uldrijan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stjepan Uldrijan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stjepan Uldrijan. The network helps show where Stjepan Uldrijan may publish in the future.

Co-authorship network of co-authors of Stjepan Uldrijan

This figure shows the co-authorship network connecting the top 25 collaborators of Stjepan Uldrijan. A scholar is included among the top collaborators of Stjepan Uldrijan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stjepan Uldrijan. Stjepan Uldrijan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozubík, Kateřina Staňo, Magdalena Skalnı́ková, Tomáš Loja, et al.. (2024). A novel thrombocytopenia‐4‐causing CYCS gene variant decreases caspase activity: Three‐generation study. British Journal of Haematology. 205(6). 2450–2458. 5 indexed citations
2.
Uldrijan, Stjepan, et al.. (2023). A forskolin-mediated increase in cAMP promotes T helper cell differentiation into the Th1 and Th2 subsets rather than into the Th17 subset. International Immunopharmacology. 125(Pt B). 111166–111166. 4 indexed citations
3.
Cruz, Jorge Oliver‐De La, Soraia Fernandes, Marco Cassani, et al.. (2022). Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture. Scientific Reports. 12(1). 17409–17409. 54 indexed citations
4.
Growková, Kateřina, Amandine Verlande, Radek Jorda, et al.. (2020). CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells. Cell Death and Disease. 11(9). 24 indexed citations
6.
Verlande, Amandine, Michaela Krafčíková, David Potěšil, et al.. (2017). Metabolic stress regulates ERK activity by controlling KSR‐RAF heterodimerization. EMBO Reports. 19(2). 320–336. 12 indexed citations
7.
Growková, Kateřina, Amandine Verlande, Jitka Mlčochová, et al.. (2017). A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. PLoS ONE. 12(10). e0185801–e0185801. 19 indexed citations
8.
Uldrijan, Stjepan, et al.. (2017). Ubiquitin-specific peptidase 48 regulates Mdm2 protein levels independent of its deubiquitinase activity. Scientific Reports. 7(1). 43180–43180. 23 indexed citations
10.
Uldrijan, Stjepan, et al.. (2015). A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity. PLoS ONE. 10(12). e0144753–e0144753. 3 indexed citations
11.
Ustianenko, Dmytro, Dominika Hroššová, David Potěšil, et al.. (2013). Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs. RNA. 19(12). 1632–1638. 143 indexed citations
13.
Vousden, Karen H., et al.. (2012). Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability. FEBS Letters. 586(16). 2225–2231. 9 indexed citations
14.
Uldrijan, Stjepan, et al.. (2011). Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. Journal of Dermatological Science. 62(1). 22–35. 59 indexed citations
15.
Kryštof, Vladimı́r & Stjepan Uldrijan. (2010). Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs. Current Drug Targets. 11(3). 291–302. 122 indexed citations
16.
Uldrijan, Stjepan, Willem‐Jan Pannekoek, & Karen H. Vousden. (2006). An essential function of the extreme C‐terminus of MDM2 can be provided by MDMX. The EMBO Journal. 26(1). 102–112. 139 indexed citations
17.
Schuh, Kai, et al.. (2003). Interaction of the Plasma Membrane Ca2+ Pump 4b/CI with the Ca2+/Calmodulin-dependent Membrane-associated Kinase CASK. Journal of Biological Chemistry. 278(11). 9778–9783. 91 indexed citations
18.
Uldrijan, Stjepan, et al.. (2002). Regulation of the p53 Tumour Suppressor Stability and Activity. Chemické listy. 96(3). 2 indexed citations
19.
Uldrijan, Stjepan, et al.. (2002). Regulace stability a aktivity nádorového supresoru p53. Chemické listy. 96(96). 145–149. 3 indexed citations
20.
Uldrijan, Stjepan, et al.. (2001). Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases. Cellular and Molecular Life Sciences. 58(9). 1333–1339. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026